Skip to main content
(305) 555-0142

Enrolling study

Migraine Prevention Research Study

A study evaluating an investigational approach to migraine prevention in adults with frequent migraine days each month.

Contact us to pre-screenPhase IIStatus: Recruiting

About this study

Participants record migraine days in a daily diary and attend scheduled visits where the study team reviews symptoms and safety information.

Condition
Migraine
Age range
18–65
Estimated duration
About 6 months
Study visits
6

Eligibility snapshot

  • Adults 18–65 years of age
  • History of migraine for at least one year
  • Four or more migraine days per month
  • Able to complete a daily electronic diary

What to expect

  1. 1Screening and informed consent visit
  2. 2Approximately 6 study visits
  3. 3Daily electronic headache diary
  4. 4Neurologic assessments performed by trained staff

Compensation

Compensation for time and travel may be available.

Learn more

Location & Principal Investigator

8500 Example Medical Plaza, Suite 210, Miami, FL 33176

Studies at this site are conducted by our Principal Investigators and research staff.

Meet the research team

Frequently asked questions

Answers to questions we hear most often.

What does participation involve?

Participation involves scheduled study visits with assessments defined by the protocol. Everything that will be asked of you is described in the informed consent document before you decide.

How long is the study?

The estimated duration is listed above. Your coordinator will review the full visit schedule with you during the consent process.

Will I be compensated for time and travel?

Where compensation is offered, the amount and payment schedule are described in the informed consent document and reviewed with you before enrollment.

What are the eligibility requirements?

The listing above shows a high-level snapshot. Full criteria are defined in the protocol and confirmed by the study team at a screening visit.

Can I leave the study at any time?

Yes. Participation is voluntary and you may withdraw at any time. Your coordinator will discuss any recommended safety follow-up.

Is my information kept confidential?

Yes. Access is limited to delegated study staff, and information shared with the sponsor is coded wherever the protocol allows.

Think you may qualify?

Contact us to learn more. A short conversation is all it takes to find out whether a screening visit makes sense.

Contact us to pre-screen

This study is conducted under IRB oversight in accordance with Good Clinical Practice guidelines. Eligibility is confirmed by the study team; the information here is a summary and not a full protocol.